Report Detail

Pharma & Healthcare Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2019

  • RnM3313944
  • |
  • 12 April, 2019
  • |
  • Global
  • |
  • 104 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Gastrointestinal Stromal Tumor (GIST) Drug market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gastrointestinal Stromal Tumor (GIST) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastrointestinal Stromal Tumor (GIST) Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others

Segment by Application
Clinic
Hospital
Others


Table of Contents

    Executive Summary

      1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview

      • 1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug
      • 1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
        • 1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Amcasertib
        • 1.2.3 Anagrelide hydrochloride CR
        • 1.2.4 APG-1351
        • 1.2.5 Binimetinib
        • 1.2.6 Others
      • 1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
        • 1.3.1 Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market by Region
        • 1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size
        • 1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2014-2025)
        • 1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production (2014-2025)

      2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers

      • 2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Production Sites, Area Served, Product Types
      • 2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
        • 2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
        • 2.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Regions

      • 3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Regions
      • 3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Production
        • 3.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production
        • 3.5.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Gastrointestinal Stromal Tumor (GIST) Drug Production (2014-2019)
        • 3.6.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production (2014-2019)
        • 3.7.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions

      • 4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions
      • 4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2014-2019)
      • 4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2014-2019)
      • 4.4 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2014-2019)
      • 4.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption (2014-2019)

      5 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2014-2019)
      • 5.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth by Type (2014-2019)

      6 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis by Applications

      • 6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Gastrointestinal Stromal Tumor (GIST) Drug Business

      • 7.1 Ariad Pharmaceuticals, Inc.
        • 7.1.1 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Arog Pharmaceuticals, Inc.
        • 7.2.1 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Array BioPharma Inc.
        • 7.3.1 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Astex Pharmaceuticals, Inc.
        • 7.4.1 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Blueprint Medicines Corporation
        • 7.5.1 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Boston Biomedical, Inc.
        • 7.6.1 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Calithera Biosciences, Inc.
        • 7.7.1 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Chipscreen Biosciences Ltd
        • 7.8.1 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Deciphera Pharmaceuticals, LLC
        • 7.9.1 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 F. Hoffmann-La Roche Ltd.
        • 7.10.1 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
        • 7.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
        • 7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Horizon Pharma Plc
      • 7.12 Immunicum AB
      • 7.13 Jiangsu Hengrui Medicine Co., Ltd.
      • 7.14 Kolltan Pharmaceuticals, Inc.
      • 7.15 Natco Pharma Limited
      • 7.16 Nerviano Medical Sciences S.r.l.
      • 7.17 Novartis AG
      • 7.18 Omeros Corporation

      8 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis

      • 8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
      • 8.4 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
      • 9.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast

      • 11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast
        • 11.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast (2019-2025)
      • 11.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Gastrointestinal Stromal Tumor (GIST) Drug . Industry analysis & Market Report on Gastrointestinal Stromal Tumor (GIST) Drug is a syndicated market report, published as Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2019. It is complete Research Study and Industry Analysis of Gastrointestinal Stromal Tumor (GIST) Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,279.40
        3,419.10
        4,558.80
        2,679.60
        4,019.40
        5,359.20
        454,082.00
        681,123.00
        908,164.00
        241,541.00
        362,311.50
        483,082.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report